What European Buyers Should Check on a Chondroitin COA

INGREDIENT INSIGHTS

What European Buyers Should Check on a Chondroitin COA

How to interpret identity, assay, contaminants and batch documentation before accepting a raw material.

A chondroitin sulfate Certificate of Analysis, or COA, should connect an identified batch with analytical results and an agreed specification. Its value depends on the information behind those results.

A statement such as “chondroitin sulfate: 90% minimum — complies” leaves important questions unanswered. Which method was used? Is the result expressed on a dry basis? Was the delivered batch tested? Does the method distinguish chondroitin from other substances?

For European buyers, a meaningful review must examine the batch identity, the analytical evidence and the relevance of the acceptance criteria.

Quick Links:

1. Confirm that the certificate belongs to the delivered batch

Start with the document itself.

Check the product name, grade, batch number, manufacturer or issuing company, certificate date, specification reference and authorised release information. Manufacturing dates, expiry or retest dates and storage conditions should be available either on the COA or through clearly linked documentation.

The batch number must correspond to the packaging and delivery records. If a distributor assigns a new lot number after repacking, request the connection to the original manufacturing batch.

A “typical COA” can illustrate expected characteristics, but it does not establish the quality of a particular shipment.

Also distinguish a retest date from an expiry date. Reaching a retest date calls for reassessment under an established procedure; it does not automatically authorise an extension of the material’s usable life.

2. Read specifications and results as different information

A specification defines what is acceptable. A result describes what was found.

For quantitative tests, a numerical result is generally more informative than “passes.” It allows the buyer to assess the margin to the limit and compare batches over time. However, a qualitative result can be appropriate for an identification test, provided its method and acceptance criteria are defined.

A useful COA usually makes four elements identifiable:

Element	What the buyer should establish
Test	The substance or property being measured
Specification	The acceptance limit and its basis
Result	The measured value or defined qualitative finding
Method	The procedure used, including its reference where applicable

Clarify whether each result comes from testing of the current batch, periodic verification or an upstream manufacturer’s report. These arrangements may be supported by a quality agreement rather than printed in full on the certificate.

3. Separate chondroitin identity from animal-origin verification

An identity test and an animal-origin declaration answer different questions.

An identity test may support the presence of chondroitin sulfate. It does not necessarily establish whether the material came from bovine cartilage, a particular fish species or a mixture of sources.

Similarly, “marine origin” is a sourcing description, not an analytical finding unless the certificate identifies a suitable test and its interpretation.

Request an origin declaration linked to the product and supporting traceability. Where analytical authentication is needed, ask what the chosen method can distinguish and what its limitations are. A routine identity result should not be presented as definitive species verification.

4. Examine the assay method before comparing percentages

Chondroitin sulfate content cannot be interpreted independently of the analytical procedure.

CPC titration is non-specific. The UK Government Chemist recommends complementary structurally informative methods where needed, including chondroitin-specific enzymatic hydrolysis followed by HPLC or mass spectrometry. A high CPC result alone does not establish identity and purity. [1]

“HPLC” is also not a complete method description. Ask for the method reference, sample preparation, reference standard and what is quantified.

In particular, distinguish a quantitative chondroitin assay from a disaccharide profile expressed as relative percentages. A profile describing the distribution of identified disaccharides is not automatically a measurement of the total chondroitin content of the powder.

5. Check whether the assay is reported on a dry basis

Two identical percentages can describe different quantities of material.

Consider a hypothetical ingredient with a chondroitin assay of 90.0% on a dry basis and 8.0% moisture. If the moisture value is appropriate for that correction, its calculated as-is content is:

90.0% × (1 − 0.08) = 82.8%

Under those assumptions, 1,000 mg of powder contains approximately 828 mg of assayed chondroitin, rather than 900 mg.

This is an illustrative calculation, not a recommended specification. It also depends on the assay’s definition and the validity of the moisture correction.

Check whether the COA reports water content or loss on drying. They are not necessarily interchangeable: loss on drying can include volatile substances other than water. Avoid applying a second correction when the reported assay already includes it.

6. Review impurities separately from chondroitin content

A high assay does not replace an impurity assessment.

Depending on the source, manufacturing process and specification, relevant checks may include residual protein, other glycosaminoglycans, free sulfate, chlorides and process-related residues.

These measurements answer different questions. For example, a total protein result does not identify a particular allergenic protein. An ash result does not provide individual concentrations of lead, cadmium or mercury.

Interpret inorganic measurements in relation to the ingredient’s chemistry and method. For a sodium salt, the inorganic residue should not automatically be treated as foreign contamination.

The appropriate panel should follow a documented risk assessment. It should not be copied from another ingredient without considering whether the tests are meaningful.

7. Assess contaminants using applicable limits and suitable methods

A generic line such as “heavy metals: complies” provides limited information. Request individual results for the elements relevant to the specification, with units and analytical methods.

EU Regulation 2023/915 establishes maximum levels for specified contaminants and food categories. Buyers should identify the applicable category and product stage; limits for a finished food supplement should not automatically be copied as universal limits for every bulk ingredient. Processing and concentration provisions may also matter. [2]

Distinguish legal requirements from contractual limits, which may be stricter. For arsenic, also distinguish total arsenic from inorganic arsenic where the latter is the relevant measurement.

If a risk assessment calls for process-related or residue testing, including semicarbazide (SEM), request the analyte, method, result and reporting limit. “Not tested” and “not detected” are different statements.

8. Interpret ND and LOQ correctly

“ND,” “not detected” and “below LOQ” do not mean zero.

The laboratory should define its notation and, where relevant, provide:

LOD: the limit of detection.
LOQ: the limit of quantification.
The reporting threshold and units.

Suppose a contractual maximum is 0.10 mg/kg, but the laboratory reports only <0.50 mg/kg. That result does not demonstrate compliance with the tighter limit: a concentration between 0.10 and 0.50 mg/kg remains possible.

Results close to an acceptance limit also require an appropriate decision rule. Measurement uncertainty should be considered according to the applicable regulatory or contractual framework, rather than added or subtracted arbitrarily. [3]

9. Read microbiological results with their test conditions

Microbiological results need units and, for presence–absence testing, a defined test portion.

“Salmonella: absent in 25 g” is more informative than “Salmonella: negative” without a stated sample quantity. Neither statement demonstrates that the whole batch is sterile.

Review the selected organisms, enumeration methods, sample plan and acceptance criteria. Depending on the risk assessment, the specification may include aerobic counts, yeasts and moulds, and selected pathogens or hygiene indicators.

EU microbiological criteria apply to defined foods and circumstances. The buyer must identify the criteria relevant to the product rather than assume a single universal legal microbiological specification for chondroitin powder. [4]

10. Decide whether the evidence supports acceptance

Before accepting the batch, use a short review checklist.

Question	Reason to request clarification
Does the COA match the delivered material?	Missing or inconsistent batch identification
Is the assay interpretable?	No method or dry/as-is reporting basis
Are results distinguishable from specifications?	Only acceptance limits are shown
Are contaminant measurements sufficiently sensitive?	Reporting limits exceed acceptance limits
Are microbiological findings defined?	Missing units, test portions or methods
Change control	Written notification and approval arrangements
Is the certificate properly controlled?	Unclear issuer, version or release authorisation
Are supporting documents consistent?	Origin, grade or batch details conflict

A missing detail does not necessarily mean that the material is defective. It means that the available evidence may be insufficient for a release decision.

Resolve important discrepancies before use. Depending on their significance, this may require a corrected certificate, the original laboratory report, independent testing or an investigation under the agreed quality procedure.

Conclusion

A useful chondroitin COA should allow the buyer to understand what was tested, on which batch, by which method and against which requirement.

Neither a high assay nor a list of “passes” establishes complete suitability. Reliable acceptance depends on coherent batch documentation, interpretable results, appropriate detection capability and specifications relevant to the intended use.